World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
45
Citations
8648
World Ranking
6888
National Ranking
195

John Mitrofanis publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where John Mitrofanis sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 149 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

John Mitrofanis D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where John Mitrofanis sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 45 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Neuroscience
  • Internal medicine
  • Neuron

John Mitrofanis focuses on Neuroscience, Anatomy, Zona incerta, Parkinson's disease and Nucleus. His Neuroscience study frequently involves adjacent topics like Subthalamic nucleus. His studies deal with areas such as Retina and Cell biology as well as Anatomy.

He has included themes like Sensory system and Diencephalon in his Zona incerta study. The Parkinson's disease study which covers Neuroprotection that intersects with Anesthesia, Tyrosine hydroxylase and Endocrinology. His Substantia nigra research focuses on subjects like Pharmacology, which are linked to Pars compacta.

His most cited work include:

  • Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease (923 citations)
  • Some certainty for the "zone of uncertainty"? Exploring the function of the zona incerta. (179 citations)
  • Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys (178 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Neuroscience, Anatomy, MPTP, Substantia nigra and Internal medicine. John Mitrofanis studied Neuroscience and Deep brain stimulation that intersect with Adverse effect. John Mitrofanis has researched Anatomy in several fields, including Retina and Brainstem.

His work is dedicated to discovering how MPTP, Neuroprotection are connected with Parkinson's disease, Pathology and Neurotoxin and other disciplines. His research integrates issues of Stereology and Gliosis in his study of Substantia nigra. His study in Endocrinology extends to Internal medicine with its themes.

He most often published in these fields:

  • Neuroscience (58.20%)
  • Anatomy (27.05%)
  • MPTP (33.61%)

What were the highlights of his more recent work (between 2016-2021)?

  • Neuroscience (58.20%)
  • Parkinson's disease (21.31%)
  • Neuroprotection (24.59%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Neuroscience, Parkinson's disease, Neuroprotection, Disease and MPTP. His Neuroscience study is mostly concerned with Striatum, Putamen, Dopaminergic Cell, Tyrosine hydroxylase and Default mode network. His Striatum research incorporates themes from Basal ganglia, Dopaminergic and Midbrain.

His research on Tyrosine hydroxylase often connects related topics like Substantia nigra. His Parkinson's disease research incorporates elements of Sound, Physical medicine and rehabilitation and MEDLINE. His MPTP research is multidisciplinary, incorporating perspectives in Neurotoxin, Pharmacology and Pars compacta.

Between 2016 and 2021, his most popular works were:

  • Photobiomodulation-induced changes in a monkey model of Parkinson’s disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum (15 citations)
  • Acquired Resilience: An Evolved System of Tissue Protection in Mammals. (13 citations)
  • The behavioural and neuroprotective outcomes when 670nm and 810nm near infrared light are applied together in MPTP-treated mice. (13 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Neuron
  • Neuroscience

John Mitrofanis mostly deals with Neuroscience, Dopaminergic Cell, MPTP, Tyrosine hydroxylase and Substantia nigra. His work carried out in the field of Neuroscience brings together such families of science as Internal medicine and Cerebral blood flow. His Dopaminergic Cell research is multidisciplinary, incorporating elements of Striatum, Neurology, Parenchyma and Macaque.

The various areas that he examines in his MPTP study include Stereology, Neuroprotection, Pharmacology and Pars compacta. His Tyrosine hydroxylase research is multidisciplinary, relying on both Dopaminergic, Tyrosine hydroxylase immunohistochemistry and Midbrain. His Substantia nigra study combines topics from a wide range of disciplines, such as Basal ganglia, Gliosis, Parvalbumin and Neuroglia.

Best Publications

  • Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease

    Alim Louis Benabid;Stephan Chabardes;John Mitrofanis;Pierre Pollak

  • Some certainty for the "zone of uncertainty"? Exploring the function of the zona incerta.

    J. Mitrofanis

  • Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys

    Bradley A. Wallace;Keyoumars Ashkan;Claire E Heise;Kelly D Foote

  • New views of the thalamic reticular nucleus in the adult and the developing brain

    Unknown

  • Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment.

    Victoria E. Shaw;Sharon Spana;Keyoumars Ashkan;Alim-Louis Benabid

  • Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease

    Daniel M. Johnstone;Cécile Moro;Jonathan Stone;Alim-Louis Benabid

  • Evidence for a large projection from the zona incerta to the dorsal thalamus

    Brian D. Power;Christian I. Kolmac;John Mitrofanis

  • Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex – evidence from two transgenic mouse models

    Sivaraman Purushothuman;Daniel M Johnstone;Charith Nandasena;John Mitrofanis

  • Origin of retinal astrocytes in the rat: evidence of migration from the optic nerve.

    Tailoi Ling;John Mitrofanis;Jonathan Stone

  • Patterns of connections between zona incerta and brainstem in rats.

    Christian I. Kolmac;Brian D. Power;John Mitrofanis

  • Organisation of the cortical projection to the zona incerta of the thalamus.

    John Mitrofanis;Lilijana Mikuletic

  • Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism - an abscopal neuroprotective effect.

    D.M. Johnstone;N. el Massri;C. Moro;S. Spana

  • Organisation of the reticular thalamic projection to the intralaminar and midline nuclei in rats

    Christian I. Kolmac;John Mitrofanis

  • Distribution of various neurochemicals within the zona incerta: an immunocytochemical and histochemical study.

    Christian Kolmac;J. Mitrofanis

  • Therapeutic electrical stimulation of the central nervous system.

    Alim-Louis Benabid;Bradley Wallace;John Mitrofanis;Celine Xia

  • Photobiomodulation enhances nigral dopaminergic cell survival in a chronic MPTP mouse model of Parkinson's disease.

    Cassandra Peoples;Sharon Spana;Keyoumars Ashkan;Alim-Louis Benabid

  • The mechanical cause of age-related dementia (Alzheimer's disease): the brain is destroyed by the pulse.

    Jonathan Stone;Daniel M Johnstone;John Mitrofanis;Michael F O'Rourke

  • Near-infrared light is neuroprotective in a monkey model of Parkinson disease.

    Fannie Darlot;Cécile Moro;Nabil El Massri;Claude Chabrol

  • Organization of the Visual Reticular Thalamic Nucleus of the Rat

    Kristina A Coleman;John Mitrofanis

  • Photobiomodulation inside the brain: a novel method of applying near-infrared light intracranially and its impact on dopaminergic cell survival in MPTP-treated mice

    Cécile Moro;Nabil El Massri;Napoleon Torres;David Ratel

  • A putative generalized model of the effects and mechanism of action of high frequency electrical stimulation of the central nervous system.

    Alim-Louis Benabid;Bradley Wallace;John Mitrofanis;Rong Xia

  • Patterns of brainstem projection to the thalamic reticular nucleus

    Christian I. Kolmac;John Mitrofanis

Frequent Co-Authors

Jonathan Stone
Jonathan Stone University of Sydney
Alim-Louis Benabid
Alim-Louis Benabid Grenoble Alpes University
Keyoumars Ashkan
Keyoumars Ashkan King's College London
Jan M. Provis
Jan M. Provis Australian National University
Glen Jeffery
Glen Jeffery University College London
Luke A. Henderson
Luke A. Henderson University of Sydney
Valérie Fraix
Valérie Fraix Grenoble Alpes University
Paul Krack
Paul Krack University of Bern
Stephan Chabardes
Stephan Chabardes Grenoble Alpes University
Pierre Pollak
Pierre Pollak Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing John Mitrofanis

Trending Scientists

Recently Published Articles